MedTech News
New implant captures gut-brain signals in awake, moving animals
Scientists have been able to measure the electrical signals in the “second brain in our guts” for the first-ever time, giving renewed understanding to its interconnection with the brain.
Paradromics gets FDA green light for BCI (Brain Computer Interface) study
Paradromics announced today that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer interface (BCI).
EDAP wins FDA nod for robotic high-intensity focused ultrasound system workflows
EDAP TMS SA (Nasdaq:EDAP) announced today that the FDA granted 510(k) clearance for new workflows for its ultrasound technology.
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart
Significant milestone reached in advancing a driverless total artificial heart, strengthening Picard Medicals leadership in total artificial heart technology
Clinical tool helps predict which brain tumors will require treatment
A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately predict whether the most common type of brain tumor will grow or cause symptoms, helping doctors and patients make better-informed decisions about care.
A microRNA cocktail weakens brain tumors in preclinical trials
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.
French scientists probe mRNA’s potential to fight cancer
Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA—best known for being used in COVID-19 vaccines—in the hopes of finding a breakthrough treatment for a particularly deadly cancer.
Scientists use stem cells to model rare genetic blindness in children
Researchers at the Eye Genetics Research Unit at Children’s Medical Research Institute (CMRI) are the first in the world to use stem cells to study one of the genetic causes of Leber Congenital Amaurosis (LCA)—a rare condition that causes severe vision loss in babies and young children.